Thus, prolonged TGF-β1 exposure not only promotes more pronounced EMT but also activates a metabolic switch that allows breast cancer cells to escape the growth inhibitory effect of TGF-β1, and thereby co-develop invasive and proliferative capabilities. This evidence concerns the gene TGFB1 and breast carcinoma.